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Background: Strength training and neuromuscular electrical stimulation (NMES) are effective training modalities
for improving muscle function, exercise performance and health status in individuals with COPD. The aim of the
present study was to analyze the metabolic load of these training modalities at baseline, half-way, and at the end
of an eight-week interdisciplinary pulmonary rehabilitation program in a subgroup of individuals with COPD of the
DICES trial.
Methods: Of 24 individuals with COPD (FEV1: 34 ± 2% predicted, men: 58%, age: 66 (61–68) years), peak oxygen
uptake (VO2), peak minute ventilation (VE), heart rate, oxygen saturation and symptom scores were assessed during
HF-NMES (75 Hz), LF-NMES (15 Hz) and strength training at three moments during their pulmonary rehabilitation
program.
Results: Intervention-related peak VO2 did not change over time during HF-NMES, LF-NMES or strength training.
Intervention-related peak VE did not change over time during strength training or LF-NMES and increased slightly,
but significantly over time during HF-NMES. Peak VO2 and VE were significantly higher during strength training
compared to HF-NMES or LF-NMES. Oxygen saturation significantly decreased after the first measurements during
HF-NMES and strength training group to baseline, while no significant changes in oxygen saturation were observed
during the other measurements. Heart rate significantly increased compared to baseline in all groups at all
moments and was significantly higher after strength training compared to HF-NMES or LF-NMES. Median end
scores (points) for dyspnea, fatigue and muscle pain ranged from 1 to 3, from 0.5 to 2 and from 0 to 6 after
HF-NMES, from 2 to 3, from 2 to 5 and from 0 to 9 after LF-NMES and from 2 to 5, from 1.5 to 4 and from 0 to
28 after strength training respectively.
Conclusions: To conclude, the metabolic load and symptom scores remain acceptable low over time with
increasing training loads during HF-NMES, LF-NMES or strength training.
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Keywords: Chronic obstructive pulmonary disease, Neuromuscular electrical stimulation, Pulmonary rehabilitation,
Strength training* Correspondence: mauricesillen@ciro-horn.nl
1Department of Research & Education, CIRO+, centre of expertise for chronic
organ failure, Hornerheide 1, Horn, the Netherlands
Full list of author information is available at the end of the article
© 2014 Sillen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Sillen et al. BMC Pulmonary Medicine 2014, 14:146 Page 2 of 9
http://www.biomedcentral.com/1471-2466/14/146Background
Individuals with chronic obstructive pulmonary disease
(COPD) may suffer from lower-limb muscle weakness and
poor exercise capacity, in particular those with severe to
very severe dyspnea [1-3]. This is most probably due to
reductions in weight-bearing daily physical activities [4].
Therefore, an exercise-based pulmonary rehabilitation
program may be beneficial [5]. Severely dyspneic indi-
viduals with COPD (i.e., modified MRC dyspnea grade 3
or 4), however, are less likely to complete a pulmonary
rehabilitation program [6]. This may be due to exercise-
induced dyspnea, particularly during whole-body endur-
ance training [7]. Therefore, strength training [8] or trans-
cutaneous neuromuscular electrical stimulation (NMES)
[9,10] may be preferential alternative rehabilitative modal-
ities for severely dyspneic individuals with COPD [11,12].
These interventions are safe and effective in severely
dyspneic individuals with COPD and quadriceps muscle
weakness at baseline [13]. Indeed, lower-limb muscle
function, functional exercise performance, problematic
activities of daily life, mood status, and health status im-
proved significantly following eight weeks of strength
training, high-frequency (HF, 75 Hertz) NMES, or low-
frequency (LF, 15 Hertz) NMES [13].
A major advantage of strength training and NMES is
the relatively low metabolic load (e.g., the intervention-
related peak oxygen uptake (VO2) and ventilation (VE)),
accompanied with relatively low dyspnea symptom
scores [14,15]. The metabolic load during multiple suc-
cessive sessions of strength training has been reported
once in 11 individuals with COPD [7]. The leg press
strengthening exercise increased significantly during a
12-week pulmonary rehabilitation program (+43% of
baseline training load), accompanied by a significant in-
crease in metabolic load over time (+23% of baseline
intervention-related peak VO2; +18% of baseline
intervention-related peak VE) [7]. The metabolic load
during a session of high-frequency (HF) or low-frequency
(LF) NMES has only been measured cross-sectionally
[14,15]. Whether and to what extent the metabolic load
will remain stable over time while the NMES pulse ampli-
tude is expected to increase [16] remains currently un-
known in individuals with COPD. Moreover, the actual
course of NMES pulse amplitude has never been de-
scribed in individuals with COPD. This, however, will pro-
vide a better insight in the feasibility and efficacy of these
types of local muscle training.
The aim of the present study was to analyze the meta-
bolic load of the different local muscle training modalities
at baseline, half-way, and at the end of the eight-week pro-
gram in a subgroup of individuals with COPD who partic-
ipated in the DICES (Dyspneic Individuals with COPD:
Electrical stimulation or Strength training) trial. A priori,
we hypothesized that individuals with COPD are able toincrease the strength training load or NMES pulse ampli-
tude (irrespective of stimulation frequency), while the
metabolic load will remain stable compared to baseline.
Methods
Participants
In the DICES trial, individuals with COPD with mMRC
dyspnea grade 3 or 4 [2], and quadriceps weakness [17]
were randomly assigned to lower-limb HF-NMES (75
Hertz), lower-limb LF-NMES (15 Hertz), or lower-limb
strength training (leg extension strengthening exercise,
and leg press strengthening exercise [8,18]). These inter-
ventions took place in group sessions, twice per day, 5
times per week for 8 weeks. All sessions were supervised
by a physiotherapist. The interdisciplinary treatment was
identical for all participants, and treadmill walking or
stationary ergometry cycling was not applied during the
trial. Symptom scores for dyspnea, fatigue, and muscle
pain were assessed before and after each session [19].
The Medical Ethical Committee of the Maastricht Univer-
sity Medical Centre + (MEC 09-3-072) approved this trial,
which conformed to the principles outlined in the World
Medical Association declaration of Helsinki which was re-
vised in Seoul [20]. Details of the trial were registered at
www.trialregister.nl NTR2322) before first subject enrolment.
All patients gave written informed consent to participate in
the study and a subgroup additionally gave written informed
consent to undergo the measurements of the metabolic load.
Some of the baseline findings, and the efficacy data of the
DICES trial have been published before [21,22].
Interventions
Please, see Additional file 1 for all details.
Outcomes
Outcome assessors were blinded for treatment alloca-
tion. The investigators supervising the interventions
(MJHS, AWV) were blinded for the initial results, and
were not involved in the outcome assessment. Partici-
pants were instructed to not divulge their group alloca-
tion. Participants, who were randomly assigned to one of
the NMES groups, were blinded for the type of stimula-
tion frequency.
Quadriceps muscle function
Quadriceps muscle function (i.e., peak muscle strength
and muscle endurance), using a Biodex (Biodex System
4 Pro, Biodex Medical Systems, Inc., New York, USA).
Quadriceps peak muscle strength (Newton-meter, Nm)
and quadriceps muscle endurance (Joules, J) were mea-
sured isokinetically. The participants performed thirty
volitional maximal contractions at an angular velocity of
90° per second. See Additional file 1 for all details con-
cerning the interventions.
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Functional exercise performance was measured with the
6-min walk test, including a practice walk at initial as-
sessment [23]. The best 6-min walk distance (6MWD)
was used for further analyses. The constant work-rate
cycling endurance test (CWRT, expressed in seconds)
was performed at 75% of the pre-determined peak cyc-
ling rate, which has a high reliability in individuals with
COPD [24]. Symptom scores for exercise-induced dys-
pnea and fatigue were assessed before and after these ex-
ercise tests.
Metabolic load
Continuous on-line calculations of breath-by-breath
oxygen uptake (VO2) and minute ventilation (VE), heart
rate and oxygen saturation were obtained using theFigure 1 Flow diagram of measurements metabolic load.Oxycon mobile, a portable metabolic system (Carefusion
the Netherlands, Houten, the Netherlands). The meta-
bolic load was measured during sessions of HF-NMES,
LF-NMES, or strength training in the first week, the
fourth week, and in the last week of the trial. This meth-
odology has been used before in individuals with COPD
[14,15]. See Additional file 1 for all details concerning
the measurement of the metabolic load.Statistical analysis
Analyses were performed using SPSS for Windows, Ver-
sion 17.0.1 (SPSS, Inc., Chicago, Il, USA). Descriptive sta-
tistics were presented as median and interquartile range
unless otherwise stated. Differences within groups were
analyzed using Wilcoxon signed rank test. Groups were
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one-way analysis of variance. All tests were two-sided
using a significance level of 5%.
Results
Baseline characteristics
Of the 120 individuals who participated in the DICES
trial, 61 individuals (51%) were ineligible for the add-
itional metabolic data collection due to the use of long-
term oxygen therapy. Moreover, 26 individuals (22%) did
not consent to this extra set of tests and 3 individuals
(2%) who gave informed consent withdrew before start.Table 1 General characteristics
Total group HF-NMES
n = 24 n = 9
Sex (M/F) 14/10 6/3
Age (years) 66 (61–68) 64 (59–67
Pulmonary function
FEV1 (liters ) 0.98 (0.78-1.05) 1.01 (0.84
FEV1 (% predicted) 35 (29–51) 34 (23–51
FEV1/VC max (%) 32 (24–43) 31 (24–41
DLCO (%) 42 (36–55) 41 (31–55
RV (%) 177 (136–235) 190 (137–
Arterial blood gases
PaO2 (kPa) 9.8 (8.8-10.8) 9.0 (8.5-1
PaCO2 (kPa) 4.9 (4.7-5.5) 5.4 (4.8-5
SaO2 (%) 96 (95–97) 95 (95–97
GOLD classification (I/II/III/IV) 0/7/10/7 0/3/3/3
GOLD classification (new) (A/B/C/D) 0/3/0/21 0/2/0/7
BMI (kg/m2) 25.4 (22.2-29.8) 25.4 (21.9
FFMI (kg/m2) 17.0 (15.8-18.5) 16.9 (15.7
Cardiopulmonary exercise test
Peak load (watts) 47 (35–57) 51 (35–57
Peak load (% predicted) 33 (23–47) 26 (23–39
Peak VO2 ( ml/min) 841 (710–987) 751 (697–
Peak VO2 (% predicted) 48 (33–73) 31 (27–64
Peak VE (liters) 33 (29–39) 38 (28–41
Peak VE (% MVV) 89 (78–107) 84 (72–98
Peak HR (bpm) 104 (98–124) 103 (98–1
Peak HR (% predicted) 71 (64–75) 66 (64–73
Dyspnea, end (points) 7 (5–8) 7 (5–7.5)
Fatigue, end (points) 5 (3–7) 5 (3.5-7.5
Saturation, end (%) 91 (89–95) 93 (91–98
Values expressed as median (interquartile range) or numbers. Data are compared b
Abbreviations: HF-NMES = High-frequency transcutaneous neuromuscular electrical s
stimulation; M =males; F = females; FEV1 = forced expiratory volume in one second;
carbon monoxide; RV = residual volume; PaO2 = resting arterial oxygen tension; PaC
tension; kPa = kilopascal; LTOT = long-term oxygen therapy; GOLD = Global Initiative
index; kg/m2 = kilogram per square meter; VO2 = oxygen uptake; tSaO2 = transcutan
maximal voluntary ventilation; bpm = beats per minute.At baseline, from 30 individuals (25%) intervention-
related peak VO2, VE, heart rate and oxygen saturation
were obtained. From 24 individuals the metabolic load
was measured during a session of HF-NMES (n = 9), LF-
NMES (n = 7), or strength training (n = 8) in the first
week, the fourth week, and in the last week of the trial
(Figure 1).
The 24 individuals of this pre-specified sub-analysis
had severe to very severe COPD, a poor diffusing cap-
acity for carbon monoxide and a poor functional and
peak exercise performance (Table 1). Besides age and the
relative peak ventilation during the cardiopulmonaryLF-NMES Strength training P-value
n = 7 n = 8
4/173 4/4 0.791
) 62 (59–67) 71 (66–77) 0.012
-1.19) 0.74 (0.60-0.84) 1.00 (0.96-1.10) 0.010
) 30 (20–38) 46 (43–60) 0.064
) 25 (24–29) 42 (33–52) 0.057
) 42 (34–61) 46 (40–56) 0.802
243) 208 (172–260) 146 (128–178) 0.081
0.9) 9.6 (8.5-9.9) 10.3 (9.4-11.2) 0.284
.7) 5.0 (4.7-5.6) 4.8 (4.6-5.1) 0.159
) 95 (94–97) 97 (96–98) 0.166
0/0/4/3 0/4/3/1 0.025
0/0/0/7 0/1/0/7 0.427
-26.9) 24.6 (23.5-30.3) 26.9 (21.5-31.1) 0.834
-17.5) 16.5 (15.7-18.8) 17.4 (15.8-19.1) 0.680
) 46 (41–62) 44 (30–58) 0.867
) 38 (22–81) 39 (23–63) 0.481
919) 817 (734–1087) 904 (699–1076) 0.473
) 53 (40–90) 52 (40–115) 0.142
) 32 (25–35) 35 (29–44) 0.553
) 103 (95–119) 81 (68–101) 0.040
22) 126 (104–131) 102 (90–109) 0.080
) 75 (68–83) 70 (63–72) 0.186
7 (7–9) 8 (5–9.5) 0.526
) 5 (3–7) 4 (3–7) 0.861
) 90 (89–91) 94 (89–96) 0.132
etween HF-NMES, LF-NMES and strength training.
timulation; LF-NMES = Low-frequency transcutaneous neuromuscular electrical
VC max =maximum vital capacity; DLCO = diffusion capacity of the lung for
O2 = resting arterial carbon dioxide tension; SaO2 = resting arterial oxygen
on Obstructive Lung Diseases; BMI = body mass index; FFMI = fat free mass
eous oxygen saturation; ml/min =milliliters per minute; % MVV = percentage
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differ between intervention groups (Table 1). Mean FEV1
(34 ± 2% versus 31 ± 1% pred), PaCO2 (5.2 ± 0.1 kPa ver-
sus 5.8 ± 0.1 kPa), fat-free mass index (17.2 ± 0.4 kg/m2
versus 16.3 ± 0.2 kg/m2) and total work (1389 ± 95 J ver-
sus 1122 ± 49 J) were significantly higher in the meta-
bolic load group compared to the remaining group,
other baseline characteristics (age, DLco, residual volume,
PaO2, SO2, peak and functional exercise performance,
body mass index, peak torque, HADS anxiety and depres-
sion and health status) were not significantly different be-
tween both groups (Additional file 1: Table S1).Efficacy of interventions
Quadriceps muscle strength
Isokinetic quadriceps peak torque increased significantly
following HF-NMES (12.6 Nm (3.0-17.5 Nm); p = 0.021),
but not following LF-NMES (4.2 Nm (−5.2-5 Nm); p =
0.866) or strength training (5.7 Nm (−9-22 Nm); p =
0.263) (Figure 2). There were no significant between-
group differences in changes.Quadriceps muscle endurance
Isokinetic total work increased significantly following
HF-NMES (292 J (156–501 J); p < 0.01), but not follow-
ing LF-NMES (12 J (−73-178 J); p = 0.499) or strength
training (157 J (−185-456 J); p = 0.263) (Figure 2). TheA
D E
B
Figure 2 Individual changes in quadriceps peak torque and total wor
transcutaneous neuromuscular electrical stimulation; LF-NMES=low-frequen
peak torque: A, B and C; quadriceps muscle endurance: D, E and F). The bimprovement following HF-NMES was significantly
higher compared to LF-NMES (p = 0.005) (Figure 2).
Six-minute walk distance
6MWD improved significantly following HF-NMES
(75 m (29–138 m); p = 0.008) or strength training (57 m
(32–85 m); p = 0.034), but not following LF-NMES
(27 m (−34-65 m); p = 0.310). There were no significant
differences in changes between groups.
Constant work-rate test
Endurance time during the constant work-rate cycling
test improved significantly following HF-NMES (92 s
(49–275 s); p = 0.066), LF-NMES (83 s (−7-223 s); p =
0.091) or strength training (37 s (1–98 s); p = 0.043). There
were no significant differences in changes between groups.
Course of HF-NMES, LF-NMES or strength training
In the HF-NMES group, pulse amplitude ranged from
12 to 40 mA in week one to 34 to 71 mA in week eight
(p = 0.008); and in the LF-NMES group from 25 to
50 mA to 35 to 98 mA (p = 0.063, Figure 3). Median end
dyspnea scores, end fatigue scores and end muscle pain
scores ranged from 1 to 3 points, from 0.5 to 2 points
and from 0 to 6 points in the HF-NMES group and from
2 to 3 points, from 2 to 5 points and from 0 to 9 points
in the LF-NMES group respectively. The load during leg
extension strengthening exercise ranged from 2.5 toF
C
k from baseline to end. Abbreviations: HF-NMES=high-frequency
cy transcutaneous neuromuscular electrical stimulation (quadriceps
old line represents the median values.
A B
C D
Figure 3 Course in pulse amplitude and training load during
the rehabilitation program. Course in pulse amplitude is shown
during HF-NMES (A) and LF-NMES (B). Course in training load is
shown during leg extension exercise (C) and leg press (D). Data are
shown as median and interquartile range. Abbreviations: HF-
NMES=high-frequency transcutaneous neuromuscular electrical




Figure 4 Course in VO2 and ventilation during HF-NMES,
LF-NMES and strength training. Course in VO2 is shown in A and
course in ventilation (VE) is shown in B. Data are shown as median and
interquartile range. Abbreviations: HF-NMES=high-frequency transcutaneous
neuromuscular electrical stimulation; LF-NMES=low-frequency transcutaneous
neuromuscular electrical stimulation; VO2=oxygen uptake. *p<0.05.
Table 2 Oxygen uptake and ventilation during HF-NMES,
LF-NMES or strength training
HF-NMES LF-NMES Strength training
n = 9 n = 8 n = 7
VO2 ml/min 424 (312–438) 369 (323–512) 630 (593–759)
VE L/min 19 (15–22) 20 (15–24) 26 (23–33)
VO2 ml/min 387 (345–418) 454 (335–530) 659 (576–754)
VE L/min 17 (16–20) 21 (16–25) 30 (25–33)
VO2 ml/min 438 (366–619) 447 (329–518) 725 (603–861)
VE L/min 21 (17–25) 20 (15–24) 30 (27–33)
Values expressed as median (interquartile range).
Abbreviations: HF-NMES = high-frequency transcutaneous neuromuscular
electrical stimulation; LF-NMES = low-frequency transcutaneous neuromuscular
electrical stimulation; VO2 = oxygen uptake; VE = ventilation; ml/min =milliliters
per minute; L/min = liters per minute.
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from 5 to 70 kg to 35 to 90 kg for the leg press strength-
ening exercise (both p < 0.02, Figure 3). In addition, me-
dian end dyspnea scores, end fatigue scores and end
muscle pain scores ranged from 2 to 5 points, from 1.5
to 4 points and from 0 to 28 points in the strength train-
ing group.
Metabolic load during HF-NMES, LF-NMES or strength
training
Intervention-related peak VO2 did not change over time
all three interventions (Figure 4A, Table 2). Intervention-
related peak VE did not change over time in the strength
training or LF-NMES group (p > 0.171). In the HF-NMES
group, the intervention-related VE increased slightly, but
significantly over time (p = 0.012, Figure 4B). At all meas-
urement points, intervention-related peak VO2 and VE
were significantly higher during strength training sessions
compared to the HF-NMES or LF-NMES sessions (all p <0.05). There were no differences between HF-NMES and
LF-NMES (p > 0.28). Oxygen saturation (lowest values)
was significant lower at the end of the fist measurements
in the HF-NMES group and the strength training group
compared with baseline (both p < 0.03), during the other
measurements no significant changes in oxygen saturation
were observed (all p > 0.05) (Table 3). There were no sig-
nificant between-group differences in changes in oxygen
saturation (all p > 0.05). Heart rate was significantly higher
at the end compared to baseline in all groups in all
Table 3 Oxygen saturation and peak heart rate during HF-NMES, LF-NMES or strength training
HF-NMES LF-NMES Strength training
n = 9 n = 8 n = 7
Pre Post P-value Pre Post P-value Pre Post P-value
First measurement
SpO2 % 96 (92–97) 93 (91–95) 0.020 89 (86–96) 88 (84–95) 0.059 95 (89–95) 91 (84–93) 0.027
Heart rate bpm 83 (77–87) 92 (82–97) 0.007 95 (80–106) 100 (85–112) 0.042 66 (60–91) 86 (77–102) 0.018
Second measurement
SpO2 % 93 (88–97) 91 (88–95) 0.056 94 (92–98) 92 (85–96) 0.066 92 (90–94) 88 (88–91) 0.149
Heart rate bpm 83 (78–89) 91 (85–100) 0.012 87 (85–97) 100 (93–106) 0.018 74 (58–89) 93 (75–109) 0.012
Third measurement
SpO2 % 93 (89–98) 93 (89–97) 0.666 87 (85–96) 92 (84–94) 0.498 95 (91–96) 91 (88–94) 0.058
Heart rate bpm 82 (73–90) 91 (88–101) 0.008 84 (77–98) 94 (82–106) 0.043 76 (62–93) 93 (79–109) 0.018
Values expressed as median (interquartile range).
Abbreviations: HF-NMES = high-frequency transcutaneous neuromuscular electrical stimulation; LF-NMES = low-frequency transcutaneous neuromuscular electrical
stimulation; SpO2 = oxygen saturation; bpm = beats per minute.
Sillen et al. BMC Pulmonary Medicine 2014, 14:146 Page 7 of 9
http://www.biomedcentral.com/1471-2466/14/146measurements (p < 0.05) (Table 3). During all measure-
ments, changes in heart rate were significantly higher
after strength training compared to HF-NMES or LF-
NMES (p < 0.04).
Discussion
This is the first study to investigate the metabolic load of
various local muscle training modalities in severely dys-
pneic COPD patients with quadriceps muscle weakness
during the course of an inpatient pulmonary rehabilitation
program. It showed that the metabolic load measured dur-
ing successive sessions of strength training, HF-NMES, or
LF-NMES remained generally stable, while the NMES
pulse amplitude or the strength training load increased
significantly during the eight-week intervention period.
The median oxygen uptake during the baseline session
of HF-NMES, LF-NMES or strength training ranged be-
tween 30 and 99% of the peak aerobic capacity measured
during the cardiopulmonary exercise test, and was com-
parable with previous studies [7,14,15]. The median oxy-
gen uptake was 99% of the peak aerobic capacity in one
subject who was characterized with very severe COPD
(FEV1: 17% pred) and a very decreased exercise capacity
(peak load: 20% pred; VO2 peak: 688 ml/min (26%
pred)). At all measurement points, intervention-related
peak VO2 and VE were significantly lower during NMES
(LF and HF) compared with strength training. This is in
line with previous studies measuring the metabolic load
in patients with COPD during NMES or strength train-
ing [14,15]. However, these results are in contrast with
the findings of a study in healthy male recreational ath-
letes comparing one session of voluntary contractions
with one session of HF-NMES (75 Hz) [25]. Theurel and
colleagues found that the average oxygen consumption
and ventilation were significantly higher during HF-
NMES compared with voluntary exercise [25]. Besidesthe study design and subjects, an important difference
with the present study is the training load [25]. Theurel
and colleagues used an average training load in strength
training of 46% of the maximal voluntary contraction in-
stead of 60-70% of the one-repetition maximum which
is used in our study and what is recommended by the
American College of Sports Medicine [8].
The present study shows no changes over time in the
metabolic load which is not in line with the study of
Probst and colleagues [7]. Probst and colleagues showed
a significant increase in oxygen uptake and ventilation
during a 12 wk program of leg press exercises [7]. This
could be attributable to a greater increase in the training
load. However, the change in training load of leg press
exercises was comparable to the present study.
The median increase in pulse amplitude during the
study was 24 mA in HF-NMES and 37 mA in LF-
NMES. The course in pulse amplitude is comparable
with previous studies in severely disabled patients with
COPD which respond to NMES [16,26]. The low meta-
bolic load accompanied with acceptable low dyspnea
and fatigue scores probably explains the applicability of
these interventions in severely disabled and dyspneic pa-
tients, even during acute COPD exacerbations [26-28].
This is also probably the reason that NMES can easily
be applied in bed-bound individuals with chronic hyper-
capnic respiratory failure due to COPD who are receiv-
ing mechanical ventilation [29] or critically ill patients in
the intensive care unit [30].
Because of the constant metabolic load in combination
with stable symptom scores over time, it seems reason-
able to hypothesize that the improvements in muscle
function are at least partially due to intramuscular
changes. Previously, it has been shown that type I and
IIa fibers increased following LF-NMES [31,32] or HF-
NMES [33,34]. Strength training generally results in
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crease in percentage and size of type II fibers [36-39].
Obviously, this study has some limitations. First, the
inclusion criteria of the DICES trial limits the external
validity of the present findings. Only COPD patients
with an mMRC score of 3 and 4 in combination with
muscle weakness were included. Secondly, the small
sample size and selected patient characteristics for par-
ticipation in the measurements with the Oxycon mobile
may be an important reason for detecting no significant
improvements in peak muscle strength in the strength
training group and quadriceps muscle endurance in the
LF-NMES group and the strength training group. Only
patients without long-term oxygen therapy (LTOT) were
eligible to participate due to the methodology used [7],
although LTOT patients are also likely to have benefit
from these interventions. However, the equipment (Oxy-
con mobile, a portable metabolic system) is not able to
measure oxygen uptake (VO2) while breathing inspira-
tory O2 fractions [7]. In the DICES trial 51% of the pa-
tients used LTOT [40]. It is unclear if the metabolic load
might be different in LTOT patients. Moreover, the
small sample size and the exclusion of LTOT patients
may limit the external validity and broad applicability of
these findings.Conclusion
To conclude, the metabolic load and symptom scores
for dyspnea, fatigue and muscle pain remain acceptable
low over time with increasing training loads during HF-
NMES, LF-NMES or strength training. For this reason,
these interventions are recommended in severely dys-
pneic patients with COPD for improving their muscle
function and exercise performance.Additional file
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